Johnson & Johnson has launched an interactive 'Gut Tunnel' experience in Singapore to highlight the importance of endoscopic remission in inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The initiative aims to educate patients and the public on the role of mucosal healing in improving long-term outcomes.
The 'Gut Tunnel' uses immersive visuals and simulations to demonstrate how inflammation damages the intestinal lining and how achieving endoscopic remission—where the gut lining appears normal under a scope—can reduce symptoms and prevent disease progression. The experience is part of J&J's broader commitment to advancing IBD care.
According to J&J, the tunnel was developed with input from gastroenterologists and patient advocates. It is located at a public venue in Singapore and is free to visitors. The company notes that IBD affects millions globally, and early diagnosis and treatment are critical.
